The import of vaccines for human use to Canada shows a steady increase in the forecast period from 2024 to 2028. The anticipated value for 2024 is USD 730.63 million, with subsequent annual increases leading to USD 829.42 million by 2028. This indicates a consistent upward trend in vaccine imports.
Year-on-year growth from 2024 to 2025 is projected, continuing this positive trend through 2028, reflecting a robust demand. The compound annual growth rate (CAGR) over the five-year forecast period is a helpful indicator of this sustained growth, highlighting Canada's increasing reliance on imported vaccines.
Future trends to watch for include potential impacts of global supply chain disruptions, changes in public health policies, and technological advancements that may affect vaccine production and import dynamics. The role of new market entrants or partnerships may also influence the import landscape significantly.
